• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泻药的不良反应。

Adverse effects of laxatives.

作者信息

Xing J H, Soffer E E

机构信息

Department of Gastroenterology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

出版信息

Dis Colon Rectum. 2001 Aug;44(8):1201-9. doi: 10.1007/BF02234645.

DOI:10.1007/BF02234645
PMID:11535863
Abstract

Laxatives are among the most commonly used drugs or additives. Most are quite safe when used judiciously, intermittently when possible, and in the absence of contraindications. Bulking agents and nonabsorbable compounds such as lactulose can cause bloating but have very few serious adverse effects except for the allergic reaction to psyllium preparations. Osmotic laxatives containing poorly absorbable ions such as magnesium or phosphate can cause metabolic disturbances, particularly in the presence of renal impairment. However, if taken intermittently, in the absence of conditions such as ileus or bowel obstruction, they have few adverse effects. Polyethylene glycol solutions are emerging as an effective and safe mode of treatment for chronic constipation. Of stimulant laxatives, senna compounds and bisacodyl are the most commonly used. Although there are data to support the neoplastic potential of this class of drugs in in vitro studies, epidemiologic data in humans so far has not established a clear link between these laxatives and colonic neoplasia. The link between stimulant laxatives and structural changes, such as the "cathartic colon" or enteric nerve damage, is not well established either. Danthron compounds should be avoided because of hepatotoxicity.

摘要

泻药是最常用的药物或添加剂之一。大多数泻药在谨慎使用、尽可能间歇性使用且无禁忌证的情况下是相当安全的。容积性泻药和不可吸收的化合物(如乳果糖)可能会导致腹胀,但除了对车前草制剂的过敏反应外,很少有严重的不良反应。含有难以吸收的离子(如镁或磷酸盐)的渗透性泻药可引起代谢紊乱,尤其是在肾功能损害的情况下。然而,如果间歇性服用,在不存在肠梗阻或肠道梗阻等情况时,它们几乎没有不良反应。聚乙二醇溶液正成为治疗慢性便秘的一种有效且安全的方法。在刺激性泻药中,番泻叶化合物和比沙可啶是最常用的。虽然有数据支持这类药物在体外研究中的致癌潜力,但迄今为止人类的流行病学数据尚未证实这些泻药与结肠肿瘤之间存在明确联系。刺激性泻药与结构变化(如“泻药性结肠”或肠神经损伤)之间的联系也尚未明确确立。由于具有肝毒性,应避免使用丹蒽醌化合物。

相似文献

1
Adverse effects of laxatives.泻药的不良反应。
Dis Colon Rectum. 2001 Aug;44(8):1201-9. doi: 10.1007/BF02234645.
2
Adverse effects of drugs used in the management of constipation and diarrhoea.用于治疗便秘和腹泻的药物的不良反应。
Drug Saf. 1994 Jan;10(1):47-65. doi: 10.2165/00002018-199410010-00004.
3
Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).Cochrane系统评价:渗透性和刺激性泻药用于儿童便秘管理(综述)
Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893.
4
Osmotic and stimulant laxatives for the management of childhood constipation.用于治疗儿童便秘的渗透性和刺激性泻药。
Cochrane Database Syst Rev. 2012 Jul 11(7):CD009118. doi: 10.1002/14651858.CD009118.pub2.
5
Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review.非处方治疗慢性便秘的疗效和安全性:一项更新的系统评价。
Am J Gastroenterol. 2021 Jun 1;116(6):1156-1181. doi: 10.14309/ajg.0000000000001222.
6
Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited.慢性刺激性泻药引起的结肠解剖结构改变:再探泻剂性结肠。
J Clin Gastroenterol. 1998 Jun;26(4):283-6. doi: 10.1097/00004836-199806000-00014.
7
Management of chronic constipation in patients with diabetes mellitus.糖尿病患者慢性便秘的管理
Indian J Gastroenterol. 2017 Jan;36(1):11-22. doi: 10.1007/s12664-016-0724-2. Epub 2016 Dec 17.
8
Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge.综述文章:刺激性泻药会损害肠道吗?对现有知识的批判性分析。
Therap Adv Gastroenterol. 2024 Jun 16;17:17562848241249664. doi: 10.1177/17562848241249664. eCollection 2024.
9
Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety?刺激性泻药的长期治疗——有效性和安全性的临床证据?
Scand J Gastroenterol. 2019 Jan;54(1):27-34. doi: 10.1080/00365521.2018.1563806. Epub 2019 Jan 31.
10
Constipation--modern laxative therapy.便秘——现代泻药疗法
Support Care Cancer. 2003 Nov;11(11):679-85. doi: 10.1007/s00520-003-0525-x. Epub 2003 Sep 20.

引用本文的文献

1
Magnesium Balance in Chronic Kidney Disease: Mineral Metabolism, Immunosuppressive Therapies and Sodium-Glucose Cotransporter 2 Inhibitors.慢性肾脏病中的镁平衡:矿物质代谢、免疫抑制治疗与钠-葡萄糖协同转运蛋白2抑制剂
Int J Mol Sci. 2025 Jun 13;26(12):5657. doi: 10.3390/ijms26125657.
2
Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial.金合欢纤维或益生菌补充剂缓解便秘为主的 IBS 患者的胃肠道不适:为期 4 周的随机双盲安慰剂对照干预试验。
Eur J Nutr. 2024 Aug;63(5):1983-1994. doi: 10.1007/s00394-024-03398-8. Epub 2024 Apr 23.
3
Development and validation of a clinical score for early diagnosis of constipation in critically ill children.
开发和验证一种用于危重症儿童早期便秘诊断的临床评分。
Sci Rep. 2023 Sep 8;13(1):14822. doi: 10.1038/s41598-023-41674-5.
4
Study on Anti-Constipation Effects of Baroni through a Novel Strategy of Network Pharmacology Screening.基于网络药理学筛选策略的巴罗尼抗便秘作用研究。
Int J Mol Sci. 2023 Mar 2;24(5):4844. doi: 10.3390/ijms24054844.
5
Magnesium Administration in Chronic Kidney Disease.镁在慢性肾脏病中的应用。
Nutrients. 2023 Jan 20;15(3):547. doi: 10.3390/nu15030547.
6
Fatal complication caused by laxative suppository agent on pediatric patient with hydrocephalus on ventriculo-peritoneal shunt: a case report.通便栓剂致脑积水脑室-腹腔分流术后患儿致命并发症:病例报告。
Childs Nerv Syst. 2023 Jun;39(6):1657-1662. doi: 10.1007/s00381-023-05874-8. Epub 2023 Feb 10.
7
Baboon syndrome with lactulose: An apparently inert drug causing a systemic reaction.乳果糖所致狒狒综合征:一种看似无害的药物引发的全身反应。
Indian J Pharmacol. 2022 Nov-Dec;54(6):464-465. doi: 10.4103/ijp.ijp_449_22.
8
The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes.乳果糖药物疗法在糖尿病治疗和预防中的潜在作用。
Front Endocrinol (Lausanne). 2022 Sep 15;13:956203. doi: 10.3389/fendo.2022.956203. eCollection 2022.
9
Effects of Elobixibat on Constipation and Lipid Metabolism in Patients With Moderate to End-Stage Chronic Kidney Disease.依洛比昔巴特对中重度至终末期慢性肾脏病患者便秘及脂质代谢的影响
Front Med (Lausanne). 2022 Jan 17;8:780127. doi: 10.3389/fmed.2021.780127. eCollection 2021.
10
Efficacy of Natural Formulation Containing Activated Charcoal, Calcium Sennosides, Peppermint Oil, Fennel Oil, Rhubarb Extract, and Purified Sulfur (Nucarb®) in Relieving Constipation.含活性炭、番泻叶苷钙、薄荷油、茴芹油、大黄提取物和精制硫磺的天然配方(Nucarb®)缓解便秘的疗效。
Cureus. 2021 Oct 1;13(10):e18419. doi: 10.7759/cureus.18419. eCollection 2021 Oct.